Rosetta Omics
PrivateLast Round
Pre Seed
May 1, 2024
Total Funding Raised
$375,000
Company Overview
Rosetta Omics is a biotechnology company that develops an AI-enabled spatial and multiomics platform to predict treatment response in solid tumors from a single tissue slide.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Drug Discovery, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rosetta Omics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Rosetta Omics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 1, 2024 |
Key People
Founding team and executive leadership
Rosetta Omics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agoranov | Pre Seed |
| Bpifrance | Pre Seed |
| 165 Global | Pre Seed |
| Saudi Biotechnology Accelerator | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2024
Grew 150% QoQ from 2 to 5 employees.
Rosetta Omics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rosetta Omics's valuation, stock price, and market status.